Healthtech Startups

Aroa Biosurgery develops soft tissue repair and wound management products based on its AROA ECM extracellular matrix platform, including bioscaffolds for acute and chronic wounds, surgical reconstruction, and hernia repair. Its products, such as Endoform, Myriad Matrix, and Symphony, are used by surgeons and clinicians for soft tissue repair and reconstruction.

3 investors

Arrae creates natural, science-backed wellness supplements for women that address everyday health concerns like bloating, sleep, and weight management. The company sells directly to consumers and through retail partnerships including Target, Ulta, and Sprouts.

3 investors

Aruna Bio develops a proprietary neural exosome platform and a lead therapeutic neural cell-derived exosome, AB126, designed to cross the blood-brain barrier. The company targets acute neurological conditions and chronic neurodegenerative diseases through mechanisms that reduce neuro-inflammation and promote neuro-protection and neuro-regeneration.

3 investors

Ascend is a gene-to-GMP development partner that helps life-science companies advance advanced therapy products from the research bench through clinical stages. It provides expertise and collaboration to support the development and manufacturing of these therapies.

3 investors

AskBio is a gene therapy company developing adeno-associated virus (AAV)-based genetic medicines for rare and other diseases, with clinical programs such as AB-1009 for late-onset Pompe disease. It operates as a wholly owned, independent subsidiary of Bayer AG.

3 investors

AskSAMIE curates adaptive equipment, services, and educational resources for aging in place, helping older adults and people with changing abilities maintain independence in their homes. Founded by occupational therapists, the platform connects customers with products and services that improve accessibility and home functionality.

3 investors

Aspirion provides AI-powered revenue cycle management and denials management services to healthcare providers and hospitals. The company combines artificial intelligence, automation, and human expertise to help healthcare institutions recover accurate and timely reimbursements, manage claims denials, and optimize cash flow.

3 investors

Assuric offers an AI-based compliance platform built for the healthtech sector. It replaces spreadsheet-driven, manual processes so digital health and AI companies can meet regulatory requirements more quickly and get products deployed sooner.

3 investors

Astek Diagnostics develops a diagnostic platform for rapid and accurate detection of urinary tract infections and related conditions in clinical specimens. The company serves physicians and patients needing point-of-care diagnostic solutions for infectious diseases.

3 investors

ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments. The company operates in the preclinical and clinical stage biotechnology space.

3 investors

Atea is a clinical-stage biopharmaceutical company developing oral direct-acting antiviral therapies for single-stranded RNA viruses, currently focused on a bemnifosbuvir and ruzasvir regimen in Phase 3 development for hepatitis C virus (HCV). Its work spans antiviral drug discovery, medicinal chemistry, biology, and virology.

3 investors

AtheroMed was a Menlo Park medical device company that developed the Phoenix Atherectomy System, a catheter-based device to mechanically remove arterial plaque in peripheral artery disease patients.

3 investors

Atia Vision develops OmniVu, a modular shape-changing dual-optic intraocular lens (IOL) that uses the eye's natural accommodative mechanism to restore near, intermediate, and distance vision for cataract patients. The device is investigational and not yet available for sale.

3 investors

Caldera Medical develops surgical solutions for women's health conditions including stress urinary incontinence, pelvic organ prolapse, polyps, and fibroids. The company serves surgeons globally and operates a humanitarian program focused on expanding treatment access to underserved women.

3 investors

Atomo Diagnostics develops diagnostic ecosystems and mobile applications for point-of-care testing, including whole-blood cassettes and reader devices compatible with smartphones for remote diagnostics. The company serves clinicians and self-test users in the in-vitro diagnostics and digital health markets.

3 investors

Atticus Pharma develops immunodermatology therapeutics using patented sustained-release technology for enhanced delivery to the viable epidermis. The company focuses on dermatological treatments leveraging its proprietary drug delivery platform.

3 investors

Audibene sells hearing aids and related digital solutions for people with hearing loss through Germany's largest network of partnered acousticians. The company combines smart hearing device technology with personalized consultation and audiologist services.

3 investors

Aurinia is a biopharmaceutical company developing therapies for autoimmune diseases with significant unmet medical needs. The company's marketed product LUPKYNIS treats active lupus nephritis, and it is also developing aritinercept for broader autoimmune indications.

3 investors

Avant builds and administers custom health insurance plans for employers, leveraging alternative provider models, reference-based pricing, and direct contracts to reduce costs. The platform offers integrated benefits administration with analytics, care coordination, and a digital member experience.

3 investors

Avelios develops a digital platform for hospitals to enable modern AI-based treatments and improve patient care through data-driven processes. The platform addresses digitization gaps in healthcare institutions that prevent adoption of advanced clinical technologies.

3 investors

Aviant operates autonomous drone logistics services in Scandinavia, transporting medical items such as blood, COVID, water, and milk samples as well as windmill farm equipment for healthcare and industrial customers. It also runs Kyte, a consumer drone home-delivery service, and holds BVLOS flight permissions from the Norwegian CAA.

3 investors

Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea. Based in the Minneapolis area, it targets mild-to-moderate OSA patients who cannot tolerate CPAP.

3 investors

Avizia provides a digital care platform integrating technology, services, and devices to support care delivery across in-person, virtual, and automated settings for providers, payers, and patients. The company operates in the healthcare technology sector, serving clinicians and healthcare organizations.

3 investors

Avol operates a drone delivery network for hospitals, flying time-critical medical payloads such as blood, organs, tissue, stem cells, and diagnostics between facilities in temperature-validated, cold-chain containers compatible with UN3373 and OPTN standards. It targets 100-400 mile routes at prices comparable to or below road courier costs, with operations anchored in St. Louis and Brooklyn.

3 investors